This serendipitous finding led to further investigation into GLP-1s potential as a weight loss aid, ultimately leading to its approval for this indication
The SOUL trial (NCT06659718) will investigate the effect of semaglutide on cardiovascular outcomes in patients with T2DM who have preexisting cardiovascular disease and/or CKD
If pregnancy occurs during treatment, the medication should be discontinued to avoid potential risks to the unborn child or nursing infant
How we reviewed this article: George N
Butyrate is a preferred energy source for gut epithelial cells, and it plays a vital role in maintaining health in humans, Zeybel points out
Wegovy pen (semaglutide, FDA-approved for chronic weight management): $1,349.02 per 28-day package, per Novo Nordisk